DE69836484D1 - Endogene retrovirale sequenzen, verwandten mit auto-immune krankheiten oder mit schwangerschaftsstörungen - Google Patents

Endogene retrovirale sequenzen, verwandten mit auto-immune krankheiten oder mit schwangerschaftsstörungen

Info

Publication number
DE69836484D1
DE69836484D1 DE69836484T DE69836484T DE69836484D1 DE 69836484 D1 DE69836484 D1 DE 69836484D1 DE 69836484 T DE69836484 T DE 69836484T DE 69836484 T DE69836484 T DE 69836484T DE 69836484 D1 DE69836484 D1 DE 69836484D1
Authority
DE
Germany
Prior art keywords
sequences
endographed
auto
immune diseases
retroviral sequences
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69836484T
Other languages
English (en)
Other versions
DE69836484T2 (de
Inventor
Frederic Beseme
Jean-Luc Blond
Olivier Bouton
Bernard Mandrand
Francois Mallet
Herve Perron
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biomerieux SA
Original Assignee
Biomerieux SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomerieux SA filed Critical Biomerieux SA
Application granted granted Critical
Publication of DE69836484D1 publication Critical patent/DE69836484D1/de
Publication of DE69836484T2 publication Critical patent/DE69836484T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Reproductive Health (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Emergency Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rehabilitation Therapy (AREA)
  • Pain & Pain Management (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Obesity (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
DE69836484T 1997-07-07 1998-07-06 Endogenes Retrovirales Genomnukliinelement, das mit einer Autoimmunkrankheit und/oder Schwengerschaftsstörungen verbunden ist, Verwendung als Marker Expired - Lifetime DE69836484T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9708815 1997-07-07
FR9708815 1997-07-07
PCT/FR1998/001442 WO1999002696A1 (fr) 1997-07-07 1998-07-06 Sequences retroviraux endogenes, associees a des maladies auto-immunes et/ou a des perturbations de la grossesse

Publications (2)

Publication Number Publication Date
DE69836484D1 true DE69836484D1 (de) 2007-01-04
DE69836484T2 DE69836484T2 (de) 2007-09-13

Family

ID=9509116

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69836484T Expired - Lifetime DE69836484T2 (de) 1997-07-07 1998-07-06 Endogenes Retrovirales Genomnukliinelement, das mit einer Autoimmunkrankheit und/oder Schwengerschaftsstörungen verbunden ist, Verwendung als Marker

Country Status (8)

Country Link
EP (1) EP1000158B1 (de)
JP (1) JP4249269B2 (de)
AT (1) ATE346153T1 (de)
AU (1) AU8447098A (de)
CA (1) CA2298834C (de)
DE (1) DE69836484T2 (de)
ES (1) ES2276468T3 (de)
WO (1) WO1999002696A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2780069B1 (fr) * 1998-06-23 2002-06-28 Inst Nat Sante Rech Med Famille de sequences nucleiques et de sequences proteiques deduites presentant des motifs retroviraux endogenes humains et leurs applications
FR2788784A1 (fr) * 1999-01-21 2000-07-28 Bio Merieux Fragment nucleique endogene associe a une maladie auto-immune, procede de marquage et reactif
EP1029917A1 (de) 1999-02-15 2000-08-23 Bio Merieux Die LTR-Region von MSRV und die durch sie kodierten Proteine, und Sonden und Methoden für Detektion des MSRV-1 Retrovirus
FR2797888A1 (fr) * 1999-09-01 2001-03-02 Bio Merieux Procede de detection de l'expression d'une proteine d'enveloppe d'un retrovirus endogene humain et utilisations d'un gene codant pour cette proteine
FR2797889A1 (fr) * 1999-09-01 2001-03-02 Bio Merieux Procede de detection de l'expression d'une proteine d'enveloppe d'un retrovirus endogene humain et utilisations d'un gene codant pour cette proteine
WO2001031021A1 (en) * 1999-10-28 2001-05-03 Universite De Geneve Multiple sclerosis-related superantigen
FR2805279B1 (fr) * 2000-02-23 2004-09-24 Jean Jacques Guilhou Sequences retrovirales associees a des affections cutanees
US20020102530A1 (en) * 2000-07-07 2002-08-01 Keith James C. Methods and compositions for diagnosing and treating preeclampsia and gestational trophoblast disorders
US20110287089A1 (en) 2009-01-13 2011-11-24 Karola Rittner Use of a saccharomyces cerevisiae mitochondrial nucleic acids fraction for immune stimulation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2689520B1 (fr) * 1992-04-03 1996-07-19 Bio Merieux Procede et milieu de culture pour l'obtention de cellules infectees par un virus associe a la sclerose en plaques.
GB2273099A (en) * 1992-11-10 1994-06-08 Asta Medica Ag Glycoprotein encoded by a human endogenous retrovirus K envelope gene
FR2731356B1 (fr) * 1995-03-09 1997-04-30 Bio Merieux Virus msrv-1 et agent pathogene et/ou infectant msrv-2 associes a la polyarthrite rhumatoide
FR2737500B1 (fr) * 1995-08-03 1997-08-29 Bio Merieux Materiel viral et fragments nucleotidiques associes a la sclerose en plaques, a des fins de diagnostic, prophylactiques et therapeutiques

Also Published As

Publication number Publication date
CA2298834A1 (fr) 1999-01-21
AU8447098A (en) 1999-02-08
ATE346153T1 (de) 2006-12-15
DE69836484T2 (de) 2007-09-13
WO1999002696A1 (fr) 1999-01-21
JP4249269B2 (ja) 2009-04-02
ES2276468T3 (es) 2007-06-16
EP1000158A1 (de) 2000-05-17
JP2002512530A (ja) 2002-04-23
EP1000158B1 (de) 2006-11-22
CA2298834C (fr) 2015-03-10

Similar Documents

Publication Publication Date Title
DK0812917T3 (da) Kuldeinducerbare promotorsekvenser
NO971493L (no) Virusmateriale og nukleotidfragmenter som er forbundet med multippel sklerose, og som kan anvendes til diagnostiske, preventive og terapeutiske formål
ATE123806T1 (de) Genetisch geformte neue pflanzenphenotypen.
ES2154624T1 (es) Regulacion de la expresion de la quinolato fosforribosil transferasa.
EE9900581A (xx) LAG-3 pleissimisteisendid
TR200401186T4 (tr) Rekombinant bir RNA-virüs oluşumunu yönlendirebilen nükleik asit sekansları içerikli suni kromozom yapıları.
BR0005804A (pt) Sequências de nucleotìdeos que codificam o genezwa1
NZ508439A (en) Novel endometriosis-associated gene
DE69836484D1 (de) Endogene retrovirale sequenzen, verwandten mit auto-immune krankheiten oder mit schwangerschaftsstörungen
CY1106978T1 (el) Ενζυμα φωσφοδιεστερασης
BR0005811A (pt) Sequências de nucleotìdeos codificando o gene zwa2
DK2256205T3 (da) Porphorymonas gingivalis-polypeptider og -polynukleotider
DE69433964D1 (de) Multiple-sklerose-virus
ATE317436T1 (de) Genveränderung im gen für die g$g(b)3- untereinheit des humanen g-proteins
ATE335091T1 (de) Bc200 rna, daraus abgeleitete proben und entsprechende anwendungen
HUP0001969A2 (hu) Az NNT-1 neurotróf faktor
WO1999002666A3 (fr) Materiel nucleique retroviral et fragments nucleotidiques notamment associes a la sclerose en plaques et/ou la polyarthrite rhumatoide, a des fins de diagnostic, prophylactiques et therapeutiques
BR9808278A (pt) Sequências de ácido nucleico isolado, de proteìna isolada e de dna, célula de planta transformada, e, planta
EP0905239A3 (de) Gen kodierend für Afadin-1
DE60140552D1 (de) Transglutaminase genprodukte
WO2002103017A1 (fr) Acides nucleiques isoles dans le neuroblastome
DE69536047D1 (de) MN-Gen und -Protein
DE60030734D1 (de) Mites-ähnliches element und an trankriptionsaktivierung beteiligtes element
EP1050580A4 (de) Nukleinsäurefragmente, rekombinante vektoren, welche diese enthalten und verfahren zum unterstützen der expression von strukturellen genen durch anwendung derselben
BR9708549A (pt) ácidos nucléicos genÈmicos, cdna e mrna, que codificam para polipeptìdeos com atividade il-16, processos para producão dos mesmos e sua utilizacão.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition